XIAOMI-W
01810
TRIP.COM-S
09961
JD HEALTH
06618
BILIBILI-W
09626
JD-SW
09618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 114.28%78.99M | -27.35%98.09M | -28.25%67.61M | -43.78%36.86M | -64.42%15.63M | -34.47%135.02M | -27.06%94.24M | -22.45%65.56M | 17.58%43.93M | -13.29%206.05M |
Operating income | 114.28%78.99M | -27.35%98.09M | -28.25%67.61M | -43.78%36.86M | -64.42%15.63M | -34.47%135.02M | -27.06%94.24M | -22.45%65.56M | 17.58%43.93M | -13.29%206.05M |
Cost of sales | -115.01%-71.67M | 27.42%-86.57M | 29.06%-60.81M | 44.37%-33.33M | 64.97%-14.58M | 27.94%-119.28M | 25.77%-85.72M | 21.76%-59.92M | -20.64%-41.63M | 16.05%-165.52M |
Operating expenses | -115.01%-71.67M | 27.42%-86.57M | 29.06%-60.81M | 44.37%-33.33M | 64.97%-14.58M | 27.94%-119.28M | 25.77%-85.72M | 21.76%-59.92M | -20.64%-41.63M | 16.05%-165.52M |
Gross profit | 107.37%7.31M | -26.87%11.52M | -20.10%6.8M | -37.55%3.53M | -54.29%1.05M | -61.14%15.75M | -37.99%8.51M | -29.05%5.65M | -19.47%2.3M | 0.13%40.53M |
Selling expenses | 0.44%-3.2M | -21.64%-7.32M | -10.39%-5.06M | -7.90%-3.21M | 75.74%-1.51M | -4.68%-6.02M | 11.38%-4.58M | -30.44%-2.97M | -628.72%-6.22M | 15.28%-5.75M |
Administrative expenses | 18.12%-6.53M | 16.52%-14.47M | 10.13%-11.16M | 20.42%-7.98M | 55.91%-6.2M | 11.22%-17.33M | 48.61%-12.41M | 37.57%-10.03M | -21.54%-14.07M | -2.38%-19.52M |
Research and development expenses | 20.53%-3.42M | -34.11%-13.19M | 12.50%-6.88M | 15.65%-4.31M | 1.95%-2.26M | -13.72%-9.83M | -25.51%-7.87M | -47.05%-5.1M | -57.93%-2.31M | 12.85%-8.65M |
Special items of operating profit | -2,969.09%-1.69M | -1,166.87%-18.28M | -109.44%-447K | -101.68%-55K | -133.83%-795K | -197.70%-1.44M | 87.67%4.73M | 69.67%3.28M | -10.61%2.35M | 27.99%1.48M |
Operating profit | 37.42%-7.52M | -121.12%-41.74M | -44.14%-16.74M | -30.96%-12.02M | 45.84%-9.72M | -333.38%-18.88M | 39.95%-11.61M | 22.99%-9.18M | -113.39%-17.95M | 38.19%8.09M |
Financing cost | -45.49%-339K | -17.28%-353K | -42.17%-327K | -89.43%-233K | -4.21%-99K | -312.33%-301K | 13.53%-230K | 8.89%-123K | ---95K | 75.67%-73K |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -26.40%92K |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --367K |
Earning before tax | 35.84%-7.86M | -119.49%-42.09M | -44.10%-17.07M | -31.74%-12.25M | 45.57%-9.82M | -326.30%-19.18M | 39.59%-11.84M | 22.83%-9.3M | -114.51%-18.05M | 49.24%8.47M |
Tax | -147.54%-58K | -495.93%-681K | 191.98%195K | 234.07%122K | 8,000.00%158K | 118.57%172K | 30.94%-212K | 63.16%-91K | 93.33%-2K | -484.23%-926K |
After-tax profit from continuing operations | 34.72%-7.92M | -125.06%-42.77M | -39.95%-16.87M | -29.16%-12.13M | 46.46%-9.66M | -351.79%-19.01M | 39.46%-12.06M | 23.64%-9.39M | -113.78%-18.05M | 27.52%7.55M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | 21.50%-16.58M | ---26.87M | ---19.4M | ---- | -1,911.71%-21.12M |
Earning after tax | 34.72%-7.92M | -20.20%-42.77M | 56.65%-16.87M | 57.87%-12.13M | 46.46%-9.66M | -162.14%-35.59M | -95.46%-38.92M | -134.10%-28.8M | -113.78%-18.05M | -378.80%-13.58M |
Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | -36.36%-19.42M | ---18.54M | ---13.44M | ---- | -9,028.21%-14.24M |
Minority profit | ---- | ---- | ---- | ---- | ---- | -36.36%-19.42M | -188.44%-18.54M | -446.81%-13.44M | -4,126.62%-6.51M | -9,028.21%-14.24M |
Shareholders should account for profits from continuing business | ---- | -125.06%-42.77M | -39.95%-16.87M | ---- | ---9.66M | -351.79%-19.01M | ---12.06M | ---9.39M | ---- | 27.52%7.55M |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | 141.22%2.84M | ---8.32M | ---5.97M | ---- | -669.91%-6.88M |
Profit attributable to shareholders | 34.72%-7.92M | -164.55%-42.77M | 17.21%-16.87M | 21.03%-12.13M | 16.25%-9.66M | -2,531.28%-16.17M | -51.13%-20.38M | -56.05%-15.36M | -39.21%-11.54M | -86.77%665K |
Basic earnings per share | 35.00%-0.0156 | -164.58%-0.0844 | 17.16%-0.0333 | 20.79%-0.024 | 16.23%-0.0191 | -2,553.85%-0.0319 | -51.13%-0.0402 | -56.19%-0.0303 | -39.02%-0.0228 | -86.87%0.0013 |
Diluted earnings per share | 35.00%-0.0156 | -164.58%-0.0844 | 17.16%-0.0333 | 20.79%-0.024 | 16.23%-0.0191 | -2,553.85%-0.0319 | -51.13%-0.0402 | -56.19%-0.0303 | -39.02%-0.0228 | -86.87%0.0013 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.